Government extends investment deadlines for Pharma MSMEs under Production-Linked Incentive (PLI) scheme

Key facts

• The government has granted Micro, Small and Medium Enterprises (MSMEs) in the pharmaceutical sector an additional year to complete their investment commitments under the Production-Linked Incentive (PLI) scheme.
• Companies are now required to complete their promised investments by the end of the 2026-27 financial year (FY27).
• The deadlines for meeting each of the earlier investment milestones have been extended by one financial year.
• The pharma PLI scheme was launched with a total financial outlay of Rs 15,000 crore to promote domestic manufacturing of high-value medicines and reduce import dependency.
• As of June 2026, the scheme has attracted Rs 46,744 crore in actual investment and generated 1.21 lakh jobs.
• A total of 55 companies, including 20 MSMEs, have been selected as beneficiaries under the scheme.